AMPEL BioSolutions Revenue and Competitors

Location

N/A

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • AMPEL BioSolutions's estimated annual revenue is currently $5.3M per year.(i)
  • AMPEL BioSolutions's estimated revenue per employee is $155,000

Employee Data

  • AMPEL BioSolutions has 34 Employees.(i)
  • AMPEL BioSolutions grew their employee count by 0% last year.

AMPEL BioSolutions's People

NameTitleEmail/Phone
1
CEO /CMOReveal Email/Phone
2
Director Medical Education and WritingReveal Email/Phone
3
Data ScientistReveal Email/Phone
4
Director Communications and AdministrationReveal Email/Phone
5
Clinical Operations Project ManagerReveal Email/Phone
6
Clinical operations Data ManagerReveal Email/Phone
7
Research AnalystReveal Email/Phone
8
Medical Affairs LIasionReveal Email/Phone
9
Senior Scientist: Lupus Genetics ProjectReveal Email/Phone
10
ConsultantReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$1.4M9-10%N/AN/A
#2
$4.3M284%N/AN/A
#3
$1.1M70%N/AN/A
#4
$3.5M45-52%$56.5MN/A
#5
$0.3M20%N/AN/A
#6
$4.5M2921%N/AN/A
#7
$1.9M129%N/AN/A
#8
$7M455%N/AN/A
#9
$6.7M435%N/AN/A
#10
$2M13-13%N/AN/A
Add Company

What Is AMPEL BioSolutions?

Solutions for the Next Generation of Novel Therapies. AMPEL BioSolutions is dedicated to finding the right drug for the right patient at the right time. We are a multifaceted biomedical company utilizing both data and clinical science to facilitate drug target identification and validation. Together, our team has the tools and expertise - a global understanding of the biomedical field, basic/clinical research, medicine, and risk management - to creatively and efficiently bring specific and effective solutions to the most challenging research, discovery, and developmental problems.

keywords:N/A

N/A

Total Funding

34

Number of Employees

$5.3M

Revenue (est)

0%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$6.6M346%N/A
#2
N/A3413%N/A
#3
$7.9M3410%N/A
#4
$2.7M3546%$25M
#5
$3.9M356%N/A